Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Quick Search
My eDoc
Support Wiki
Direct access to
document ID:

          Document History for Document ID 546607

Back to latest document version
Document Version Version Comment Date Status
546607.0 Automatic journal name synchronization 19.03.2011 20:15 Released

ID: 546607.0, MPI für molekulare Zellbiologie und Genetik / Publikationen MPI-CBG 2010-arch
Role of EBAG9 protein in coat protein complex I-dependent glycoprotein maturation and secretion processes in tumor cells.
Authors:Wolf, Jana; Reimer, Tatiana A; Schuck, Sebastian; Rüder, Constantin; Gerlach, Kerstin; Müller, Eva-Christina; Otto, Albrecht; Dörken, Bernd; Rehm, Armin
Date of Publication (YYYY-MM-DD):2010
Title of Journal:The FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Issue / Number:10
Start Page:4000
End Page:4019
Copyright:not available
Audience:Experts Only
Intended Educational Use:No
Abstract / Description:Many proteins mature within the secretory pathway by the acquisition of glycans. Failure to maintain the proper distribution of the glycosylation machinery might lead to disease. High expression levels of the ubiquitous Golgi protein estrogen receptor-binding fragment-associated gene 9 (EBAG9) in human tumors correlate with poor clinical prognosis, and EBAG9 overexpression in epithelial cell lines induces truncated glycans, typical of many carcinomas. Here, we addressed the pathogenetic link between EBAG9 expression and the alteration of the cellular glycome. We applied confocal microscopy, live imaging, pulse-chase labeling in conjunction with immunoprecipitation, and enzymatic activity assays in a variety of EBAG9-overexpressing or depleted epithelial tumor cell lines. EBAG9 shuttles between the ER-Golgi intermediate compartment and the cis-Golgi, and we demonstrate association of EBAG9 with coat protein complex I (COPI)-coated transport vesicles. EBAG9 overexpression imposes delay of endoplasmic reticulum-to-Golgi transport and mislocalizes components of the ER quality control and glycosylation machinery. Conversely, EBAG9 down-regulation accelerates glycoprotein transport through the Golgi and enhances mannosidase activity. Thus, EBAG9 acts as a negative regulator of a COPI-dependent ER-to-Golgi transport pathway in epithelial cells and represents a novel pathogenetic principle in which interference with intracellular membrane trafficking results in the emergence of a tumor-associated glycome.
External Publication Status:published
Document Type:Article
Version Comment:Automatic journal name synchronization
Communicated by:nn
Affiliations:MPI für molekulare Zellbiologie und Genetik